Literature DB >> 9094091

Estrogen-induced cyclin D1 and D3 gene expressions during mouse uterine cell proliferation in vivo: differential induction mechanism of cyclin D1 and D3.

D Geum1, W Sun, S K Paik, C C Lee, K Kim.   

Abstract

D-type cyclins are involved in the regulation of the G1/S transition of the cell cycle in various cell types cultured in vitro. Little is, however, known about the expression pattern and functional role of D-type cyclins in physiological processes in vivo. In this report, we studied whether the expression of murine D-type cyclins correlates with the states of mouse uterine cell proliferation in vivo. Time-course changes in cyclin D1 and D3 mRNA levels in the uterine tissues of immature mice primed with 17 beta-estradiol (E2) were examined by Northern blot hybridization. c-fos and thymidine kinase (TK) mRNA levels were also examined as markers for the transition from G0 to G1 and the onset of S phase, respectively. Cyclin D1 and D3 mRNAs were induced 2.5-fold between c-fos and TK mRNA peaks. The E2-induced cyclin D1 and D3 gene expressions were blocked by antiestrogens tamoxifen and ICI 182,780. We also investigated the effects of cycloheximide (CHX), a protein synthesis inhibitor, on cyclin D1 and D3 gene expressions. When CHX was treated alone, cyclin D3, but not cyclin D1, mRNA was immediately superinduced. The E2-induced cyclin D3 gene expression was shifted by approximately 6 h when CHX was pretreated 1 hr before E2 administration. Interestingly, the 3H-thymidine incorporation experiment showed that the mouse uterine cell cycle progression also shifted by 6 hr with pretreatment of CHX. The overall results suggest that both cyclin D1 and D3 mRNAs are constitutively expressed in uterine tissues and induced by E2 at G1 phase of the mouse uterine cell cycle. However, the superinducibility and temporal shift of cyclin D3 by CHX suggest that there is a different regulatory mechanism underlying cyclin D1 and D3 gene expressions in the mouse uterine cell cycle progression.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9094091     DOI: 10.1002/(SICI)1098-2795(199704)46:4<450::AID-MRD2>3.0.CO;2-N

Source DB:  PubMed          Journal:  Mol Reprod Dev        ISSN: 1040-452X            Impact factor:   2.609


  11 in total

1.  Evidence for coordinated interaction of cyclin D3 with p21 and cdk6 in directing the development of uterine stromal cell decidualization and polyploidy during implantation.

Authors:  Jian Tan; Shefali Raja; Marilyn K Davis; Ossama Tawfik; Sudhansu K Dey; Sanjoy K Das
Journal:  Mech Dev       Date:  2002-02       Impact factor: 1.882

2.  Multifaceted regulation of cell cycle progression by estrogen: regulation of Cdk inhibitors and Cdc25A independent of cyclin D1-Cdk4 function.

Authors:  J S Foster; D C Henley; A Bukovsky; P Seth; J Wimalasena
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

3.  Early increase in cyclin-D1 expression and accelerated entry of mouse hepatocytes into S phase after administration of the mitogen 1, 4-Bis[2-(3,5-Dichloropyridyloxy)] benzene.

Authors:  G M Ledda-Columbano; M Pibiri; R Loi; A Perra; H Shinozuka; A Columbano
Journal:  Am J Pathol       Date:  2000-01       Impact factor: 4.307

4.  NeoPalAna: Neoadjuvant Palbociclib, a Cyclin-Dependent Kinase 4/6 Inhibitor, and Anastrozole for Clinical Stage 2 or 3 Estrogen Receptor-Positive Breast Cancer.

Authors:  Cynthia X Ma; Feng Gao; Jingqin Luo; Donald W Northfelt; Matthew Goetz; Andres Forero; Jeremy Hoog; Michael Naughton; Foluso Ademuyiwa; Rama Suresh; Karen S Anderson; Julie Margenthaler; Rebecca Aft; Timothy Hobday; Timothy Moynihan; William Gillanders; Amy Cyr; Timothy J Eberlein; Tina Hieken; Helen Krontiras; Zhanfang Guo; Michelle V Lee; Nicholas C Spies; Zachary L Skidmore; Obi L Griffith; Malachi Griffith; Shana Thomas; Caroline Bumb; Kiran Vij; Cynthia Huang Bartlett; Maria Koehler; Hussam Al-Kateb; Souzan Sanati; Matthew J Ellis
Journal:  Clin Cancer Res       Date:  2017-03-07       Impact factor: 12.531

5.  Chromium-VI arrests cell cycle and decreases granulosa cell proliferation by down-regulating cyclin-dependent kinases (CDK) and cyclins and up-regulating CDK-inhibitors.

Authors:  Jone A Stanley; JeHoon Lee; Thamizh K Nithy; Joe A Arosh; Robert C Burghardt; Sakhila K Banu
Journal:  Reprod Toxicol       Date:  2011-05-20       Impact factor: 3.143

6.  Estrogen stimulates a transient increase in the number of new neurons in the dentate gyrus of the adult female rat.

Authors:  P Tanapat; N B Hastings; A J Reeves; E Gould
Journal:  J Neurosci       Date:  1999-07-15       Impact factor: 6.167

7.  An estrogen receptor-alpha/p300 complex activates the BRCA-1 promoter at an AP-1 site that binds Jun/Fos transcription factors: repressive effects of p53 on BRCA-1 transcription.

Authors:  Brandon D Jeffy; Jennifer K Hockings; Michael Q Kemp; Sherif S Morgan; Jill A Hager; Jason Beliakoff; Luke J Whitesell; G Timothy Bowden; Donato F Romagnolo
Journal:  Neoplasia       Date:  2005-09       Impact factor: 5.715

8.  Estrogen stimulates expression of p21Waf1/Cip1 in mouse uterine luminal epithelium.

Authors:  Ming-Derg Lai; Meei Jyh Jiang; Lih-Yuh C Wing
Journal:  Endocrine       Date:  2002-04       Impact factor: 3.633

Review 9.  Clinical Management of Potential Toxicities and Drug Interactions Related to Cyclin-Dependent Kinase 4/6 Inhibitors in Breast Cancer: Practical Considerations and Recommendations.

Authors:  Laura M Spring; Mark L Zangardi; Beverly Moy; Aditya Bardia
Journal:  Oncologist       Date:  2017-07-13

10.  Comparative temporal and dose-dependent morphological and transcriptional uterine effects elicited by tamoxifen and ethynylestradiol in immature, ovariectomized mice.

Authors:  Cora J Fong; Lyle D Burgoon; Kurt J Williams; Agnes L Forgacs; Timothy R Zacharewski
Journal:  BMC Genomics       Date:  2007-06-07       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.